Financials

  • Market Capitalization 239.5 M
  • Employee 106
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.81
市销率
262.27

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3479
RNAC
Cartesian Therapeutics, Inc. - Common Stock
8.68 USD+0.70%-15.32%+0.70%-5.24%255.03 M USD
3503
ACIU
AC Immune SA - Common Stock
2.37 USD-1.66%-7.42%0.00%+15.61%241.13 M USD
3518
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.57 USD-0.56%-4.29%+1.13%-54.70%237.88 M USD
3528
TARA
Protara Therapeutics, Inc. - Common Stock
4.12 USD+0.73%+0.24%+4.30%+33.77%231.56 M USD